| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.04 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.28 | 0.04 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |